Page 11234..10..»

World’s 1st Stem Cell Transplant from Donor to Man’s Eye Shows Promise of Restoring Sight – EnviroNews (registration) (blog)

By daniellenierenberg

(EnviroNews World News) Kobe, Japan For more than two million Americans, straight lines may look wavy and the vision in the center of their eye may slowly disappear.



Source Link(s) Are Here

World's 1st Stem Cell Transplant from Donor to Man's Eye Shows Promise of Restoring Sight - EnviroNews (registration) (blog)

To Read More: World’s 1st Stem Cell Transplant from Donor to Man’s Eye Shows Promise of Restoring Sight – EnviroNews (registration) (blog)
categoriaIPS Cell Therapy commentoComments Off on World’s 1st Stem Cell Transplant from Donor to Man’s Eye Shows Promise of Restoring Sight – EnviroNews (registration) (blog) | dataApril 27th, 2017
Read All

Stem cell-based treatment prevents transplant rejection, in animal study – The San Diego Union-Tribune

By JoanneRUSSELL25

Organ transplant rejection might eventually be preventable by giving recipients an immune-suppressing vaccine derived from induced pluripotent stem cells, according to a study led by Japanese researchers.



Source Link(s) Are Here

Stem cell-based treatment prevents transplant rejection, in animal study - The San Diego Union-Tribune

To Read More: Stem cell-based treatment prevents transplant rejection, in animal study – The San Diego Union-Tribune
categoriaIPS Cell Therapy commentoComments Off on Stem cell-based treatment prevents transplant rejection, in animal study – The San Diego Union-Tribune | dataApril 23rd, 2017
Read All

Cellular Dynamics International Signs Collaboration Agreement with Harvard Stem Cell Institute – Business Wire (press release)

By JoanneRUSSELL25

MADISON, Wis.–(BUSINESS WIRE)–Cellular Dynamics International (CDI), a FUJIFILM company and a leading developer and manufacturer of induced pluripotent stem cells (iPS), today announced it has signed a collaboration agreement with the Harvard Stem Cell Institute (HSCI), a novel network of stem cell scientists that extends from the University to its affiliated hospitals and the biomedical industry. The objective of the new partnership is to increase the availability of iPS cells and services to the HSCI network and the research community at large. CDI is honored and excited to partner with Harvard Stem Cell Institute, one of the worlds most prestigious research organizations, said Dr.



Source Link(s) Are Here

Cellular Dynamics International Signs Collaboration Agreement with Harvard Stem Cell Institute - Business Wire (press release)

To Read More: Cellular Dynamics International Signs Collaboration Agreement with Harvard Stem Cell Institute – Business Wire (press release)
categoriaIPS Cell Therapy commentoComments Off on Cellular Dynamics International Signs Collaboration Agreement with Harvard Stem Cell Institute – Business Wire (press release) | dataApril 20th, 2017
Read All

Plasticell And Kings College London To Collaborate In Trials Of Blood Platelet Substitute – Clinical Leader

By admin

Plasticell, a developer of cell therapies including hematopoietic cell replacement therapies, recently announced it has partnered with Kings College London to progress preclinical trials of its artificial blood platelet product, manufactured from pluripotent stem cells.



Source Link(s) Are Here

Plasticell And Kings College London To Collaborate In Trials Of Blood Platelet Substitute - Clinical Leader

To Read More: Plasticell And Kings College London To Collaborate In Trials Of Blood Platelet Substitute – Clinical Leader
categoriaIPS Cell Therapy commentoComments Off on Plasticell And Kings College London To Collaborate In Trials Of Blood Platelet Substitute – Clinical Leader | dataApril 20th, 2017
Read All

Cellular Dynamics International Signs Distribution Deal with STEMCELL Technologies – Yahoo Finance

By daniellenierenberg

MADISON, Wis.–(BUSINESS WIRE)– Cellular Dynamics International (CDI), a FUJIFILM company and a leading developer and manufacturer of induced pluripotent stem cell-derived products, today announced it has signed a distribution agreement with STEMCELL Technologies, a world leader in iPS cell culture media. This joint agreement with STEMCELL Technologies will make iPSC technology widely available to researchers worldwide, helping advance biological research leading to cellular therapies and drug discovery, said Dr. Bruce Novich, Division President-CNBD for FUJIFILM Holdings America Corporation and Executive Vice President and General Manager for CDI



Source Link(s) Are Here

Cellular Dynamics International Signs Distribution Deal with STEMCELL Technologies - Yahoo Finance

To Read More: Cellular Dynamics International Signs Distribution Deal with STEMCELL Technologies – Yahoo Finance
categoriaIPS Cell Therapy commentoComments Off on Cellular Dynamics International Signs Distribution Deal with STEMCELL Technologies – Yahoo Finance | dataApril 18th, 2017
Read All

Telomerase reverse transcriptase – Wikipedia

By LizaAVILA

TERT Identifiers Aliases TERT, CMM9, DKCA2, DKCB4, EST2, PFBMFT1, TCS1, TP2, TRT, hEST2, hTRT, telomerase reverse transcriptase External IDs OMIM: 187270 MGI: 1202709 HomoloGene: 31141 GeneCards: TERT Genetically Related Diseases breast cancer, interstitial lung disease, adenocarcinoma of the lung, prostate cancer, se atraganto con un caramelo, testicular germ cell cancer, idiopathic pulmonary fibrosis, malignant glioma[1] RNA expression pattern More reference expression data Orthologs Species Human Mouse Entrez Ensembl UniProt RefSeq (mRNA) RefSeq (protein) Location (UCSC) Chr 5: 1.25 1.3 Mb Chr 13: 73.63 73.65 Mb PubMed search [2] [3] Wikidata View/Edit Human View/Edit Mouse Telomerase reverse transcriptase (abbreviated to TERT, or hTERT in humans) is a catalytic subunit of the enzyme telomerase, which, together with the telomerase RNA component (TERC), comprises the most important unit of the telomerase complex.[4][5] Telomerases are part of a distinct subgroup of RNA-dependent polymerases. Telomerase lengthens telomeres in DNA strands, thereby allowing senescent cells that would otherwise become postmitotic and undergo apoptosis to exceed the Hayflick limit and become potentially immortal, as is often the case with cancerous cells. To be specific, TERT is responsible for catalyzing the addition of nucleotides in a TTAGGG sequence to the ends of a chromosomes telomeres.[6] This addition of repetitive DNA sequences prevents degradation of the chromosomal ends following multiple rounds of replication.[7] hTERT absence (usually as a result of a chromosomal mutation) is associated with the disorder Cri du chat.[8][9] Telomerase is a ribonucleoprotein polymerase that maintains telomere ends by addition of the telomere repeat TTAGGG.



Source Link(s) Are Here

Telomerase reverse transcriptase - Wikipedia

To Read More: Telomerase reverse transcriptase – Wikipedia
categoriaIPS Cell Therapy commentoComments Off on Telomerase reverse transcriptase – Wikipedia | dataApril 16th, 2017
Read All

Sumitomo Dainippon buys cell therapy processing tech from Hitachi – In-PharmaTechnologist.com

By admin

Sumitomo Dainippon Pharma Co Ltd has ordered cell culture technologies from Hitachi as part of its effort to develop a treatment for Parkinsons disease. The order financial terms of which were not provided will see Hitachi supply automated cell culturing technologies designed for the manufacture of induced pluripotent stem cells (iPS)



Source Link(s) Are Here

Sumitomo Dainippon buys cell therapy processing tech from Hitachi - In-PharmaTechnologist.com

To Read More: Sumitomo Dainippon buys cell therapy processing tech from Hitachi – In-PharmaTechnologist.com
categoriaIPS Cell Therapy commentoComments Off on Sumitomo Dainippon buys cell therapy processing tech from Hitachi – In-PharmaTechnologist.com | dataApril 15th, 2017
Read All

Neurotrophic factors in ALS: a winning combination? – ALS Research Forum

By LizaAVILA

Distinct growth factors promote the survival of specific types of motor neurons in the spinal cord, according to a study led by Georg Haase, of Aix-Marseille University in Marseille, France. The results suggest that these factors may work together to provide trophic support to motor neurons in the CNS and therefore, a combination of them may be needed to protect motor neurons damaged by disease. Growth factors have always been tantalizingly attractive in ALS, said Nicholas Boulis of Emory University Medical School, who was not involved in the study.



Source Link(s) Are Here

Neurotrophic factors in ALS: a winning combination? - ALS Research Forum

To Read More: Neurotrophic factors in ALS: a winning combination? – ALS Research Forum
categoriaIPS Cell Therapy commentoComments Off on Neurotrophic factors in ALS: a winning combination? – ALS Research Forum | dataApril 8th, 2017
Read All

Stem Cells Market is Expected to Cross US$ 297 Billion by 2022 – MilTech

By LizaAVILA

The global stem cells market is expected to grow at an incredible CAGR of 25.5% from 2015 to 2022 and reach a market value of US$297 billion by 2022.



Source Link(s) Are Here

Stem Cells Market is Expected to Cross US$ 297 Billion by 2022 - MilTech

To Read More: Stem Cells Market is Expected to Cross US$ 297 Billion by 2022 – MilTech
categoriaIPS Cell Therapy commentoComments Off on Stem Cells Market is Expected to Cross US$ 297 Billion by 2022 – MilTech | dataApril 8th, 2017
Read All

A Japanese Man Has Become the First Recipient of Donated … – Futurism

By daniellenierenberg

In Brief A Japanese man has become the first recipient of donated, reprogrammed stem cells as a treatment for macular degeneration. If the treatment proves effective against the age-related eye condition, it could halt or prevent the vision loss of the 10 million people in the U.S.



Source Link(s) Are Here

A Japanese Man Has Become the First Recipient of Donated ... - Futurism

To Read More: A Japanese Man Has Become the First Recipient of Donated … – Futurism
categoriaIPS Cell Therapy commentoComments Off on A Japanese Man Has Become the First Recipient of Donated … – Futurism | dataMarch 31st, 2017
Read All

Immune cell therapy on liver cancer using interferon beta …

By NEVAGiles23

March 29, 2017 (A) Bio-imaging analysis to evaluate the therapeutic effect of iPS-ML producing IFN- on metastatic liver cancer. (B) Quantification of the image data shown in A



Source Link(s) Are Here

Immune cell therapy on liver cancer using interferon beta ...

To Read More: Immune cell therapy on liver cancer using interferon beta …
categoriaIPS Cell Therapy commentoComments Off on Immune cell therapy on liver cancer using interferon beta … | dataMarch 31st, 2017
Read All

Scientist maps giant virus Phys.org Phys.Org IPS …

By admin

March 28, 2017 by Layne Cameron Kristin Parent mapped the structure of the giant Samba virus with MSUs cryo-EM microscope, which is featured on the cover of the journal Viruses. Credit: Michigan State University In a laboratory at Michigan State University, scientists took a DIY approach to build a retrofitted cryo-electron microscope that allowed them to map a giant Samba virus one of the worlds largest viruses



Source Link(s) Are Here

Scientist maps giant virus Phys.org Phys.Org IPS ...

To Read More: Scientist maps giant virus Phys.org Phys.Org IPS …
categoriaIPS Cell Therapy commentoComments Off on Scientist maps giant virus Phys.org Phys.Org IPS … | dataMarch 31st, 2017
Read All

Stem cell Wikipedia, the free encyclopedia IPS Cell …

By daniellenierenberg

Stem cells are undifferentiated biological cells that can differentiate into specialized cells and can divide (through mitosis) to produce more stem cells. They are found in multicellular organisms. In mammals, there are two broad types of stem cells: embryonic stem cells, which are isolated from the inner cell mass of blastocysts, and adult stem cells, which are found in various tissues.



Source Link(s) Are Here

Stem cell Wikipedia, the free encyclopedia IPS Cell ...

To Read More: Stem cell Wikipedia, the free encyclopedia IPS Cell …
categoriaIPS Cell Therapy commentoComments Off on Stem cell Wikipedia, the free encyclopedia IPS Cell … | dataMarch 30th, 2017
Read All

Interferon-beta producing stem cell-derived immune cell therapy on … – Science Daily

By LizaAVILA

All causes of the most common form of liver cancer, hepatocellular carcinoma (HCC), are not yet known, but the risk of getting it is increased by hepatitis B or C, cirrhosis, obesity, diabetes, a buildup of iron in the liver, or a family of toxins called aflatoxins produced by fungi on some types of food. Typical treatments for HCC include radiation, chemotherapy, cryo- or radiofrequency ablation, resection, and liver transplant.



Source Link(s) Are Here

Interferon-beta producing stem cell-derived immune cell therapy on ... - Science Daily

To Read More: Interferon-beta producing stem cell-derived immune cell therapy on … – Science Daily
categoriaIPS Cell Therapy commentoComments Off on Interferon-beta producing stem cell-derived immune cell therapy on … – Science Daily | dataMarch 29th, 2017
Read All

Three women blinded after clinical trial went wrong – Normangee Star

By LizaAVILA

But its always been clear that they could be risky too, especially if theyre not used carefully. The LCSB team has published its results in the scientific journal PLOS Biology. This study shows that for the first time, targeting the proliferating tumor mass and dormant cancer stem cells with combination therapy effectively inhibited tumor growth and prevented metastasis compared to monotherapy in mice, said Wang, who is a member of the UCLA Jonsson Comprehensive Cancer Center and of the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA



Source Link(s) Are Here

Three women blinded after clinical trial went wrong - Normangee Star

To Read More: Three women blinded after clinical trial went wrong – Normangee Star
categoriaIPS Cell Therapy commentoComments Off on Three women blinded after clinical trial went wrong – Normangee Star | dataMarch 27th, 2017
Read All

Unproven Stem Cell Treatment Blinds 3 Florida Women – ClickLancashire

By raymumme

The Food and Drug Administration recommends that people who consider getting a stem cell treatment need to make sure it has been approved or is being studied in a clinical trial that federal health regulators have allowed. The kind that have generated the most excitement – and controversy – are human embryonic stem cells, which are derived from early human embryos and can be coaxed to become any kind of cell in the body.



Source Link(s) Are Here

Unproven Stem Cell Treatment Blinds 3 Florida Women - ClickLancashire

To Read More: Unproven Stem Cell Treatment Blinds 3 Florida Women – ClickLancashire
categoriaIPS Cell Therapy commentoComments Off on Unproven Stem Cell Treatment Blinds 3 Florida Women – ClickLancashire | dataMarch 26th, 2017
Read All

Scientists know how to grow human heart tissue – Institute …

By admin

Scientists used stem cells to grow human heart tissue that contracted spontaneously in a petri dish marking progress in the quest to manufacture transplant organs. A team from the University of Pittsburgh, Pennsylvania, used induced pluripotent stem (iPS) cells generated from human skin cells to create precursor heart cells called MCPs. iPS cells are mature human cells reprogrammed into a versatile, primitive state from which they can be prompted to develop into any kind of cell of the body



Source Link(s) Are Here

Scientists know how to grow human heart tissue - Institute ...

To Read More: Scientists know how to grow human heart tissue – Institute …
categoriaIPS Cell Therapy commentoComments Off on Scientists know how to grow human heart tissue – Institute … | dataMarch 25th, 2017
Read All

We’re About to Enter a New Era in Parkinson’s Disease Treatments – Futurism

By admin

Before we get to the therapeutic stuff, here is a reminder of the main problem people with Parkinsons disease face.



Source Link(s) Are Here

We're About to Enter a New Era in Parkinson's Disease Treatments - Futurism

To Read More: We’re About to Enter a New Era in Parkinson’s Disease Treatments – Futurism
categoriaIPS Cell Therapy commentoComments Off on We’re About to Enter a New Era in Parkinson’s Disease Treatments – Futurism | dataMarch 24th, 2017
Read All

A two-step method to make microglia – Nature.com

By daniellenierenberg

A two-step method to make microglia Nature.com Microglia have been reported in some disease models to have beneficial effects; however, research into their potential as a cell therapy is limited by the lack of means to produce readily grafted, autologous microglial cells .



Source Link(s) Are Here

A two-step method to make microglia
A two-step method to make microglia - Nature.com

To Read More: A two-step method to make microglia – Nature.com
categoriaIPS Cell Therapy commentoComments Off on A two-step method to make microglia – Nature.com | dataMarch 23rd, 2017
Read All

Abnormal development of the brain in an intractable disease, thanatophoric dysplasia – Science Daily

By LizaAVILA

Abnormal development of the brain in an intractable disease, thanatophoric dysplasia Science Daily It is only possible, by using appropriate animal model that reproduces relevant pathophysiology, to uncover the process of pathogenesis and to develop therapy .



Source Link(s) Are Here

Abnormal development of the brain in an intractable disease, thanatophoric dysplasia
Abnormal development of the brain in an intractable disease, thanatophoric dysplasia - Science Daily

To Read More: Abnormal development of the brain in an intractable disease, thanatophoric dysplasia – Science Daily
categoriaIPS Cell Therapy commentoComments Off on Abnormal development of the brain in an intractable disease, thanatophoric dysplasia – Science Daily | dataMarch 19th, 2017
Read All